U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Tetracycline – Oral products
  1. Development Resources

Tetracycline – Oral products

Exceptions or additions to the recognized standards

Enterobacterales recognition includes Salmonella spp. and Shigella spp.

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Other Non-Enterobacterales

Streptococcus spp. Viridans Group

Back to Top